Unlike findings in the syngeneic CT26 colon cancer model that showed increased CD8+ T cells shortly after AMG510 treatment (5), our immunogenomic analyses revealed that AMG510-resistant tumors became immunologically cold and had significantly reduced adaptive immune cell populations. This evidence concerns the gene CD8A and colonic neoplasm.